药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Trimethaphan
Indenolol
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Vandetanib.
Trimethaphan
Dexverapamil
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Vandetanib.
Trimethaphan
Penfluridol
The risk or severity of QTc prolongation can be increased when Penfluridol is combined with Vandetanib.
Trimethaphan
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine is combined with Vandetanib.
Trimethaphan
Lorcainide
The risk or severity of QTc prolongation can be increased when Lorcainide is combined with Vandetanib.
Trimethaphan
Bunaftine
The risk or severity of QTc prolongation can be increased when Bunaftine is combined with Vandetanib.
Trimethaphan
Nizofenone
The risk or severity of QTc prolongation can be increased when Nizofenone is combined with Vandetanib.
Trimethaphan
Otilonium
The risk or severity of QTc prolongation can be increased when Otilonium is combined with Vandetanib.
Trimethaphan
Sultopride
The risk or severity of QTc prolongation can be increased when Sultopride is combined with Vandetanib.
Trimethaphan
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Sitafloxacin is combined with Vandetanib.
Trimethaphan
Oxatomide
The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Vandetanib.
Trimethaphan
Abexinostat
The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Vandetanib.
Trimethaphan
Mizolastine
The risk or severity of QTc prolongation can be increased when Mizolastine is combined with Vandetanib.
Trimethaphan
Ricolinostat
The risk or severity of QTc prolongation can be increased when Ricolinostat is combined with Vandetanib.
Trimethaphan
Simendan
The risk or severity of QTc prolongation can be increased when Simendan is combined with Vandetanib.
Trimethaphan
CUDC-101
The risk or severity of QTc prolongation can be increased when CUDC-101 is combined with Vandetanib.
Trimethaphan
Gilteritinib
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Vandetanib.
Trimethaphan
Entinostat
The risk or severity of QTc prolongation can be increased when Entinostat is combined with Vandetanib.
Trimethaphan
Mocetinostat
The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Vandetanib.
Trimethaphan
Amifampridine
The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Vandetanib.